Big Pharma makes strongest start to M&A for a decade

US tax overhaul spurs near-$30bn spree but some warn of bubble amid high valuations
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals